These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

162 related items for PubMed ID: 23902708

  • 1. Insights into the prognostic value of DJ-1 and MIB-1 in astrocytic tumors.
    Abd El Atti RM, Abou Gabal HH, Osman WM, Saad AS.
    Diagn Pathol; 2013 Jul 31; 8():126. PubMed ID: 23902708
    [Abstract] [Full Text] [Related]

  • 2. Mitosin and pHH3 predict poorer survival in astrocytomas WHO grades II and III.
    Varughese RK, Lind-Landström T, Habberstad AH, Salvesen Ø, Haug CS, Sundstrøm S, Torp SH.
    J Clin Pathol; 2016 Jan 31; 69(1):26-34. PubMed ID: 26188054
    [Abstract] [Full Text] [Related]

  • 3. The positive correlation between DJ-1 and β-catenin expression shows prognostic value for patients with glioma.
    Wang C, Fang M, Zhang M, Li W, Guan H, Sun Y, Xie S, Zhong X.
    Neuropathology; 2013 Dec 31; 33(6):628-36. PubMed ID: 23714193
    [Abstract] [Full Text] [Related]

  • 4. Expression and clinical significance of the proliferation marker minichromosome maintenance protein 2 (Mcm2) in diffuse astrocytomas WHO grade II.
    Lind-Landström T, Varughese RK, Sundstrøm S, Torp SH.
    Diagn Pathol; 2013 Apr 24; 8():67. PubMed ID: 23618321
    [Abstract] [Full Text] [Related]

  • 5. Prognostic significance of nuclear DJ-1 expression in astrocytoma.
    Miyajima Y, Sato Y, Oka H, Utsuki S, Kondo K, Tanizaki Y, Nagashio R, Tsuchiya B, Okayasu I, Fujii K.
    Anticancer Res; 2010 Jan 24; 30(1):265-9. PubMed ID: 20150646
    [Abstract] [Full Text] [Related]

  • 6. The clinical value of Ki-67/MIB-1 labeling index in human astrocytomas.
    Johannessen AL, Torp SH.
    Pathol Oncol Res; 2006 Jan 24; 12(3):143-7. PubMed ID: 16998593
    [Abstract] [Full Text] [Related]

  • 7. Practical value of MIB-1 index in predicting behavior of astrocytomas.
    Ambroise MM, Khosla C, Ghosh M, Mallikarjuna VS, Annapurneswari S.
    Indian J Pathol Microbiol; 2011 Jan 24; 54(3):520-5. PubMed ID: 21934213
    [Abstract] [Full Text] [Related]

  • 8. High level of Sema3C is associated with glioma malignancy.
    Vaitkienė P, Skiriutė D, Steponaitis G, Skauminas K, Tamašauskas A, Kazlauskas A.
    Diagn Pathol; 2015 Jun 02; 10():58. PubMed ID: 26032848
    [Abstract] [Full Text] [Related]

  • 9. MIB-1 labeling index in astrocytic tumors--a clinicopathologic study.
    Neder L, Colli BO, Machado HR, Carlotti CG, Santos AC, Chimelli L.
    Clin Neuropathol; 2004 Jun 02; 23(6):262-70. PubMed ID: 15584210
    [Abstract] [Full Text] [Related]

  • 10. Cellular proliferation in pilocytic and diffuse astrocytomas.
    Giannini C, Scheithauer BW, Burger PC, Christensen MR, Wollan PC, Sebo TJ, Forsyth PA, Hayostek CJ.
    J Neuropathol Exp Neurol; 1999 Jan 02; 58(1):46-53. PubMed ID: 10068313
    [Abstract] [Full Text] [Related]

  • 11. Prognostic significance of Ki-67 labeling indices obtained using MIB-1 monoclonal antibody in patients with supratentorial astrocytomas.
    Wakimoto H, Aoyagi M, Nakayama T, Nagashima G, Yamamoto S, Tamaki M, Hirakawa K.
    Cancer; 1996 Jan 15; 77(2):373-80. PubMed ID: 8625247
    [Abstract] [Full Text] [Related]

  • 12. Clinicopathological features, MIB-1 labeling index and apoptotic index in recurrent astrocytic tumors.
    Ralte AM, Sharma MC, Karak AK, Mehta VS, Sarkar C.
    Pathol Oncol Res; 2001 Jan 15; 7(4):267-78. PubMed ID: 11882906
    [Abstract] [Full Text] [Related]

  • 13. MIB-1 proliferation index predicts survival among patients with grade II astrocytoma.
    McKeever PE, Strawderman MS, Yamini B, Mikhail AA, Blaivas M.
    J Neuropathol Exp Neurol; 1998 Oct 15; 57(10):931-6. PubMed ID: 9786243
    [Abstract] [Full Text] [Related]

  • 14. MIB-1 labeling index in nonpilocytic astrocytoma of childhood: a study of 101 cases.
    Ho DM, Wong TT, Hsu CY, Ting LT, Chiang H.
    Cancer; 1998 Jun 15; 82(12):2459-66. PubMed ID: 9635540
    [Abstract] [Full Text] [Related]

  • 15. DJ-1: a novel independent prognostic marker for survival in glottic squamous cell carcinoma.
    Zhu XL, Wang ZF, Lei WB, Zhuang HW, Jiang HY, Wen WP.
    Cancer Sci; 2010 May 15; 101(5):1320-5. PubMed ID: 20345476
    [Abstract] [Full Text] [Related]

  • 16. Immunohistochemical analysis of metallothionein in astrocytic tumors in relation to tumor grade, proliferative potential, and survival.
    Hiura T, Khalid H, Yamashita H, Tokunaga Y, Yasunaga A, Shibata S.
    Cancer; 1998 Dec 01; 83(11):2361-9. PubMed ID: 9840536
    [Abstract] [Full Text] [Related]

  • 17. Prognostic value of survivin and DNA topoisomerase IIα in diffuse and anaplastic astrocytomas.
    Varughese RK, Skjulsvik AJ, Torp SH.
    Pathol Res Pract; 2017 Apr 01; 213(4):339-347. PubMed ID: 28214203
    [Abstract] [Full Text] [Related]

  • 18. Aberrant localization of the neuronal class III beta-tubulin in astrocytomas.
    Katsetos CD, Del Valle L, Geddes JF, Assimakopoulou M, Legido A, Boyd JC, Balin B, Parikh NA, Maraziotis T, de Chadarevian JP, Varakis JN, Matsas R, Spano A, Frankfurter A, Herman MM, Khalili K.
    Arch Pathol Lab Med; 2001 May 01; 125(5):613-24. PubMed ID: 11300931
    [Abstract] [Full Text] [Related]

  • 19. Assessment and prognostic significance of mitotic index using the mitosis marker phospho-histone H3 in low and intermediate-grade infiltrating astrocytomas.
    Colman H, Giannini C, Huang L, Gonzalez J, Hess K, Bruner J, Fuller G, Langford L, Pelloski C, Aaron J, Burger P, Aldape K.
    Am J Surg Pathol; 2006 May 01; 30(5):657-64. PubMed ID: 16699322
    [Abstract] [Full Text] [Related]

  • 20. NRF2, DJ1 and SNRX1 and their prognostic impact in astrocytic gliomas.
    Haapasalo J, Nordfors K, Granberg KJ, Kivioja T, Nykter M, Haapasalo H, Soini Y.
    Histol Histopathol; 2018 Aug 01; 33(8):791-801. PubMed ID: 29441509
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.